Evidence map›Paper›PMID 26202126›Full record

ArticleJournal of clinical microbiology2015

Characterization of Hepatitis C Virus Recombination in Cameroon by Use of Nonspecific Next-Generation Sequencing.

James C Iles, Richard Njouom, Yacouba Foupouapouognigni, David Bonsall, Rory Bowden, Amy Trebes, Paolo Piazza, Ellie Barnes, Jacques Pépin, Paul Klenerman and 1 more

Abstract read
In one paragraph

Article in Journal of clinical microbiology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed.

  1. Article
  2. DAA Treatment Failure in a HIV/HBV/HCV Co-Infected Patient Carrying a Chimeric HCV Genotype 4/1b.International journal of environmental research and public health · 2022
    Article
  3. Global Patterns of Recombination across Human Viruses.Molecular biology and evolution · 2021
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Superinfection and cure of infected cells as mechanisms for hepatitis C virus adaptation and persistence.Proceedings of the National Academy of Sciences of the United States of America · 2018
    Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Hepatitis C in Cameroon: What is the progress from 2001 to 2016?Journal of translational internal medicine · 2016
    Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

James C IlesDepartment of Zoology, University of Oxford, Oxford, United Kingdom.ORCID http://orcid.org/0000-0001-7276-9829
Richard NjouomService de Virologie, Centre Pasteur du Cameroun, Yaounde, Cameroon.
Yacouba FoupouapouognigniService de Virologie, Centre Pasteur du Cameroun, Yaounde, Cameroon.
David BonsallPeter Medawar Building for Pathogen Research, University of Oxford, Oxford, United Kingdom.
Rory BowdenWellcome Trust Centre for Human Genetics, Oxford University, Oxford, United Kingdom.
Amy TrebesWellcome Trust Centre for Human Genetics, Oxford University, Oxford, United Kingdom.
Paolo PiazzaWellcome Trust Centre for Human Genetics, Oxford University, Oxford, United Kingdom.
Ellie BarnesPeter Medawar Building for Pathogen Research, University of Oxford, Oxford, United Kingdom.
Jacques PépinDepartment of Microbiology and Infectious Diseases, Université de Sherbrooke, Sherbrooke, Canada.
Paul KlenermanPeter Medawar Building for Pathogen Research, University of Oxford, Oxford, United Kingdom.
Oliver G PybusDepartment of Zoology, University of Oxford, Oxford, United Kingdom oliver.pybus@zoo.ox.ac.uk.

Funding

Medical Research Council MR/K010239/1Medical Research Council MR/K01532X/1Wellcome Trust 091663
6 · The paper itself

Abstract

The importance of recombination in the evolution and genetic diversity of the hepatitis C virus (HCV) is currently uncertain. Only a small number of intergenotypic recombinants have been identified so far, and each has core and envelope genes classified as belonging to genotype 2. Here, we investigated two putative genotype 4/1 recombinants from southern Cameroon using a number of approaches, including standard Sanger sequencing, genotype-specific PCR amplification, and non-HCV-specific Illumina RNA sequencing (RNA-seq). Recombination between genotypes 1 and 4 was confirmed in both samples, and the parental lineages of each recombinant belong to HCV subtypes that are cocirculating at a high prevalence in Cameroon. Using the RNA-seq approach, we obtained a complete genome for one sample, which contained a recombination breakpoint at the E2/P7 gene junction. We developed and applied a new method, called Deep SimPlot, which can be used to visualize and identify viral recombination directly from the short sequence reads created by next-generation sequencing in conjunction with a consensus sequence.

Indexed as

GenotypeRecombination, GeneticAgedCameroonCluster AnalysisFemaleHepacivirusHepatitis CHigh-Throughput Nucleotide SequencingHumansMaleMiddle AgedMolecular Sequence DataPhylogenySequence Analysis, DNA

Identifiers

PMID26202126
PMCPMC4572555

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.